Spectrum Vision Partners’ OCLI Broadens Long Island Footprint with New AffiliationMay 21, 2018
Ophthalmic Consultants of Long Island (OCLI), a Spectrum Vision Partners managed practice, announced today that it has entered into a partnership with the well-respected ophthalmology practice Eye Care Associates/Glaucoma Consultants of Long Island (ECA/GCLI), with locations in Bethpage and Lake Success.
Founded in 1987 and headquartered in Bethpage, New York, Eye Care Associates/Glaucoma Consultants of Long Island has a track record of eye care clinical excellence with known expertise in the diagnosis and treatment of glaucoma. The practice is composed of seven highly-trained ophthalmologists who share a passion for providing patients with the highest quality eye care with respect and kindness.
Robert Rothman, MD of ECA/GCLI, said, “The partnership with OCLI is a natural fit with and a key milestone for our practice. We share the same vision for world-class ophthalmic patient care for Long Islanders.”
Tom Burke, CEO of Spectrum Vision Partners, commented, “Spectrum Vision Partners is thrilled to further strengthen the OCLI practice hub with the addition of the ECA/GCLI ophthalmology team of Dr.’s Arnold Prywes, Joseph Weinstein, Craig Marcus, Robert Rothman, Allison Angelilli, Daniel Hayes and Robert Auerbach. We will continue to expand our patient service locations on Long Island in collaboration with eye doctors and surgeons who are like-minded and provide clinical excellence with a passion for delivering exceptional patient care.”
As part of the transaction, all of ECA/GCLI’s physicians will maintain their current roles with the practice.
About Ophthalmic Consultants of Long Island
Founded in 1997, Ophthalmic Consultants of Long Island (www.ocli.net) is one of the leading ophthalmology practices in the United States. OCLI boasts 15 state-of-the-art medical facilities across Nassau and Suffolk counties, housing the most advanced technology available to offer patients a variety of ophthalmic services and treatments. OCLI is led by 33 highly skilled eye surgeons in each major sub-specialty of eye care, providing comprehensive eye care services, including treatment for cataracts, corneal disease, refractive surgery, glaucoma, oculoplastics, retinal disease and neuro ophthalmology. OCLI also employs 4 Doctors of Optometry, 3 Physician Assistants and 1 NYS Licensed Aesthetician.
About Eye Care Associates /Glaucoma Consultants of Long Island
Founded in 1987, Eye Care Associates and Glaucoma Consultants of Long Island (www.longislandeyedoctors.com) is one of the leading ophthalmology practices on Long Island. Eye Care Associates and Glaucoma Consultants of Long Island provide patients with comprehensive eye care services including the latest treatments for glaucoma, cataract and refractive surgery at locations in Bethpage and Lake Success. The practice is led by seven MD ophthalmologists considered experts in their field, performing the highest level of glaucoma care utilizing the most advanced diagnostic and surgical techniques.
About Spectrum Vision Partners
Spectrum Vision Partners is a leading management services organization serving the ophthalmology practice and ambulatory surgery center sector. Spectrum Vision Partners has over 650 employees providing world-class practice management solutions to a network of nationally renowned, multi-specialty ophthalmologists and optometrists in the Tri-State region. Spectrum Vision Partners provides a comprehensive set of business support functions, including revenue cycle management, marketing, financial and accounting services, human resources including benefits and payroll management and information systems management and support.
Blue Sea Capital (www.blueseacapital.com) is a private equity firm based in West Palm Beach, Florida, that invests in growth-oriented lower middle market companies with EBITDA of up to $30 million. The firm has $1.4 billion in committed capital and invests across three industry verticals: aerospace & defense, healthcare and industrial growth. Blue Sea Capital’s strategy is to partner with talented leaders and differentiated companies, typically as the first or second institutional investor, and deliver strategic and operational value-add that drives growth acceleration, industry outperformance and business transformation.